Rakhi Kumar - 20 Feb 2025 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Reporting relationship: Chief Accounting Officer
Issuer ticker: ROIV
Reported as of: 20 Feb 2025
Net transaction value: -$10,270
SEC form: 4
Accepted by SEC: 24 Feb 2025, 21:00:43 UTC
Prior SEC filing: 18 Feb 2025
Next SEC filing: 09 Jun 2025
Source filing: View source filing
Reporting owner signature: By: /s/ Jo Chen, as Attorney-in-Fact for Rakhi Kumar

Key filing fact

Rakhi Kumar filed Form 4 for Roivant Sciences Ltd. (ROIV) on 24 Feb 2025.

Key facts

This page summarizes Rakhi Kumar's Form 4 filing for Roivant Sciences Ltd. (ROIV).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 24 Feb 2025, 21:00.

Change

Previous filing in this sequence was filed on 18 Feb 2025.
Current net transaction value: -$10,270.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ROIV transaction

Common Shares

Tax liability

Transaction value: $10,270
Shares: -958
Change %: -0.59%
Price: $10.72
Shares after: 162,306
Date: 20 Feb 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Rakhi Kumar is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.